← Insider buys
RVNC

Revance Therapeutics, Inc.

CFO, CBO Lauren P Silvernail sold $87K of Revance Therapeutics, Inc.

Sold$86,924
$30.25Price
2,874Shares
−4%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Tue, May 22. Filed Thu, May 24, 3:24 PM ET, during the session. Not investment advice.